Australia markets open in 7 hours 7 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
63.97+1.73 (+2.78%)
As of 10:53AM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 125.10B
Enterprise value 155.12B
Trailing P/E 93.81
Forward P/E 7.15
PEG ratio (5-yr expected) 11.00
Price/sales (ttm)2.77
Price/book (mrq)3.36
Enterprise value/revenue 3.41
Enterprise value/EBITDA 19.51

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-0.08%
S&P500 52-week change 314.85%
52-week high 369.75
52-week low 353.22
50-day moving average 360.51
200-day moving average 363.28

Share statistics

Avg vol (3-month) 313.47M
Avg vol (10-day) 312.44M
Shares outstanding 52.22B
Implied shares outstanding 6N/A
Float 82.2B
% held by insiders 10.07%
% held by institutions 175.56%
Shares short (13 Jan 2022) 423.71M
Short ratio (13 Jan 2022) 41.9
Short % of float (13 Jan 2022) 41.07%
Short % of shares outstanding (13 Jan 2022) 41.07%
Shares short (prior month 14 Dec 2021) 421.93M

Dividends & splits

Forward annual dividend rate 42.16
Forward annual dividend yield 43.47%
Trailing annual dividend rate 31.96
Trailing annual dividend yield 33.15%
5-year average dividend yield 42.94
Payout ratio 4N/A
Dividend date 331 Jan 2022
Ex-dividend date 405 Jan 2022
Last split factor 21000000:951777
Last split date 306 Aug 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin -11.89%
Operating margin (ttm)19.49%

Management effectiveness

Return on assets (ttm)4.68%
Return on equity (ttm)-12.31%

Income statement

Revenue (ttm)45.47B
Revenue per share (ttm)20.36
Quarterly revenue growth (yoy)10.30%
Gross profit (ttm)34.05B
EBITDA 19.71B
Net income avi to common (ttm)-5.41B
Diluted EPS (ttm)-2.42
Quarterly earnings growth (yoy)-17.40%

Balance sheet

Total cash (mrq)15.82B
Total cash per share (mrq)7.13
Total debt (mrq)45.84B
Total debt/equity (mrq)122.96
Current ratio (mrq)1.47
Book value per share (mrq)16.76

Cash flow statement

Operating cash flow (ttm)15.51B
Levered free cash flow (ttm)12.1B